Continuous ST-segment monitoring: 3 case studies in progressive care

Critical Care Nurse

Volumn 29, Issue 5, 2009, Pages 18-27

  Sandau, Kristin E ^a   Smith, Maureen ^b  

^a BETHEL UNIVERSITY   (United States)

^b Nasseff Heart Center of United Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; BLOOD; ELECTROCARDIOGRAPHY; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INTENSIVE CARE; MALE; METHODOLOGY; NURSING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRACTICE GUIDELINE; PROGNOSIS; RISK ASSESSMENT; STENT;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, BALLOON; BIOLOGICAL MARKERS; CRITICAL CARE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INTENSIVE CARE; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RISK ASSESSMENT; STENTS;

EID: 75349084567     PISSN: 02795442     EISSN: None     Source Type: Journal    
DOI: 10.4037/ccn2009953     Document Type: Article

References (32)

1. Field JM, Hazinski MF, Gilmore D, eds. Handbook of Emergency Cardiovascular Care for Healthcare Providers. Dallas, TX: American Heart Association; 2006.
2. Thygesen K, Alpert JS, White HD, on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation. 2007;116:2634-2653.
3. Leeper P. Continuous ST-segment monitoring. AACN Clin Issues. 2003;14:145-154.
4. Fu GY, Joseph AJ, Antalis G. Application of continuous ST-segment monitoring in the detection of silent myocardial ischemia. Ann Emerg Med. 1994;23:1113-1115.
5. Akkerhuis KM, Klootwijk P, Lindeboom W, et al. Recurrent ischaemia during continuous multilead ST-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events. Eur Heart J. 2001;22(21):1997-2006.
6. Maas AC, Wyatt CM, Green CL, et al. Combining baseline clinical descriptors and realtime response to therapy: the incremental prognostic value of continuous ST-segment monitoring in acute myocardial infarction. Am Heart J. 2004;147(4):698-704.
7. Landesberg G, Vesselov Y, Einav S, Goodman S, Sprung CL, Weissman C. Myocardial ischemia, cardiac troponin, and long-term survival of high-cardiac risk critically ill intensive care unit patients. Crit Care Med. 2005;33(6):1281-1287.
8. Terkelsen CJ, Nørgaard BL, Lassen JF, et al. Potential significance of spontaneous and interventional ST-changes in patients transferred for primary percutaneous coronary intervention: observations from the STMONitoring in Acute Myocardial Infarction study (The MONAMI study). Eur Heart J. 2006;27:267-275.
9. Yan AT, Yan RT, Tan MT, Senaratne M, Fitchett DH, Langer A, and the INTERACT Investigators. Long-term prognostic value and therapeutic implications of continuous ST-segment monitoring in acute coronary syndrome. Am Heart J. 2007;153(4):500-506.
10. Klootwijk P, Langer A, Meij S, et al. Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trial. Eur Heart J. 1996;17(5):689-698.
11. Langer A, Krucoff MW, Klootwijk P, et al. Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy. J Am Coll Cardiol. 1998;31(4):783-789.
12. Cruden NL, Graham C, Harding SA, Ludlam CA, Fox KA, Newby DE. Plasma TAFI and soluble CD40 ligand do not predict reperfusion following thrombolysis for acute myocardial infarction. Thromb Res. 2006;118(2):189-197.
13. Klootwijk P, Meij S, Melkert R, Lenderink T, Simoons ML. Reduction of recurrent ischemia with abciximab during continuous ECG-ischemia monitoring in patients with unstable angina refractory to standard treatment (CAPTURE). Circulation. 1998;98(14):1358-1364.
14. Akkerhuis KM, Maas ACP, Klootwijk PAJ, et al. Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: relation with death and myocardial infarction. PURSUIT ECGI-schemia Monitoring Substudy Investigators. J Electrocardiol. 2000;33(2):127-136.
15. Akkerhuis KM, Neuhaus KL, Wilcox RG, et al for the Fibrinogen Receptor Occupancy STudy (FROST) Investigators. Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation: a phase II study. Eur Heart J. 2000;21(24):2042-2055.
16. Fesmire FM, Percy RF, Bardoner JB, Wharton DR, Calhoun FB. Usefulness of automated serial 12-lead ECG monitoring during the initial emergency department evaluation of patients with chest pain. Ann Emerg Med. 1998;31(1):3-11.
17. Hewer I, Drew B, Karp K, Stotts N. The utilization of automated ST-segment analysis in the determination of myocardial ischemia. AANA J. 1997;65(4):351-356.
18. Landesberg G, Mosseri M, Wolf Y, Vesselov Y, Weissman C. Perioperative myocardial ischemia and infarction. Anesthesiology. 2002;96(2):264-270.
19. Fesmire FM. Which chest pain patients potentially benefit from continuous 12-lead ST-segment monitoring with automated serial ECG? Am J Emerg Med. 2000;18:773-778.
20. Drew BJ, Krucoff MW. Multilead ST-segment monitoring in patients with acute coronary syndromes: a consensus statement for healthcare professionals. ST-Segment Monitoring Practice International Guidelines Working Group. Am J Crit Care. 1999;8(6):372-388.
21. Drew BJ, Califf RM, Funk M, et al. Practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association scientific statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: endorsed by the International Society of Computerized Electrocardiology and the American Association of Critical-Care Nurses. Circulation. 2004;110(17):2721-2746.
22. Sandau KE, Smith M. Continuous ST-segment monitoring: protocol for practice. Crit Care Nurse. 2009(4):39-51.
23. Patton JA, Funk M. Survey of use of ST-segment monitoring in patients with acute coronary syndromes. Am J Crit Care. 2001;10(1):23-34.
24. American Association of Critical-Care Nurses (AACN). AACN Practice Alert. ST-Segment Monitoring. http://www.aacn.org/WD /Practice/Docs/ST_Segment_Monitoring_ 04-2008.pdf. Accessed July 27, 2009.
25. Kucia AM, Stewart S. The role of ST-segment monitoring in assessment of acute myocardial infarction. Dimens Crit Care Nurs. 1999; 18(5):12-18.
26. Crater SW, Taylor CA, Maas AC, et al. Realtime application of continuous 12-lead ST-segment monitoring: 3 case studies. Crit Care Nurs. 2000;20(2):93-99.
27. Daleiden AM, Schell H. Setting a new gold standard: ST-segment monitoring provides early detection of myocardial ischemia. Am J Nurs. 2001;101(suppl):4-8.
28. Drew BJ, Funk M. Practice standards for ECG monitoring in hospital settings: executive summary and guide for implementation. Crit Care Nurs Clin North Am. 2006;18(2): 157-168.
29. Flanders SA. Continuous ST-segment monitoring: raising the bar. Crit Care Nurs Clin North Am. 2006;18:169-177.
30. Flanders SA. ST-segment monitoring: putting standards into practice. AACN Adv Crit Care. 2007;18(3):275-284.
31. Leeper B. Saving lives with continuous ST-segment monitoring. Am Nurs Today. 2007; February:21-14.
32. Canto JG, Shlipak MG, Rogers WJ, et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA. 2000;283(24):3223-3229.